Patents by Inventor Richard Kenley

Richard Kenley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of cachexia
    Patent number: 8080528
    Abstract: Compositions and methods for preventing and treating wasting disorders, such as cachexia and anorexia, are provided. In one aspect, the present invention provides a method for preventing and treating a wasting disorder in a mammal. In one embodiment, the method of the invention comprises administering to such mammal a macrolide and a ?2-adrenergic agonist in combination such that the macrolide and said ?2-agonist are administered in amounts effective to prevent or at least alleviate said wasting disorder.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: December 20, 2011
    Assignee: The Releef Initiative
    Inventors: Richard Kenley, Jonas Ekblom, Mikhail Denissenko
  • Compositions and Methods for Treatment of Exudative Serous Effusion
    Publication number: 20090221518
    Abstract: Compositions and methods are provided for treating accumulation of exudative serous effusions caused by illnesses such as cancer, infection, and pancreatitis. In one embodiment, the method of the invention comprises administering to such mammal a macrolide in an amount effective to prevent or at least alleviate said exudative serous effusion accumulation.
    Type: Application
    Filed: September 5, 2008
    Publication date: September 3, 2009
    Applicant: Anaborex, Inc.
    Inventors: Richard Kenley, Mikhail Denissenko
  • Sheathing/Weather Resistive Barrier Method and System
    Publication number: 20080289279
    Abstract: A sheathing product having a structural substrate with two or more edges. The sheathing product also having a weather resistive barrier attached to the structural substrate prior to securing the structural substrate to a frame of a building. A part of the weather resistive barrier extends beyond an edge of the structural substrate to create a flap that allows the weather resistive barrier to be attached to an abutting sheathing product.
    Type: Application
    Filed: May 24, 2007
    Publication date: November 27, 2008
    Applicant: TIN, INC.
    Inventors: James Hannan, Richard Kenley
  • COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CACHEXIA
    Publication number: 20070149465
    Abstract: Compositions and methods for preventing and treating wasting disorders, such as cachexia and anorexia, are provided. In one aspect, the present invention provides a method for preventing and treating a wasting disorder in a mammal. In one embodiment, the method of the invention comprises administering to such mammal a macrolide and a ?2-adrenergic agonist in combination such that the macrolide and said ?2-agonist are administered in amounts effective to prevent or at least alleviate said wasting disorder.
    Type: Application
    Filed: December 20, 2006
    Publication date: June 28, 2007
    Inventors: Richard Kenley, Jonas Ekblom, Mikhail Denissenko
  • Pharmaceutical formulations of osteogenic proteins
    Patent number: 5597897
    Abstract: A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and an osteogenic protein-sequestering material.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: January 28, 1997
    Assignee: Genetics Institute, Inc.
    Inventors: Eyal Ron, Thomas J. Turek, Benjamin S. Isaacs, Himakshi Patel, Richard A. Kenley
  • Aldoxime-substituted imidazolium derivatives useful in the treatment of poisoning by phosphorus-containing chemicals
    Patent number: 4925856
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted functionalized imidazolium compounds and compositions is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these aldoxime-substituted imidazolium derivatives has been found to save mammals having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: May 15, 1990
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Dane A. Goff, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe, Robert O. Pick
  • Aldoxime-substituted triazolium compounds useful in the treatment of poisoning by phosphorus-containing chemicals
    Patent number: 4865837
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted trazolium derivatives is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these low toxicity aldoxime-substituted triazolium derivatives has been found to save mice having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: July 28, 1987
    Date of Patent: September 12, 1989
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe